Video

Lung Cancer Stigmas Affect Patients Psychosocially, Lead to Worse Health Outcomes

Author(s):

Studies show that the social stigma can actually affect a patient’s level of care and lead to worse health outcomes.

It is well known in the oncology community that the stigma associated with lung cancer is something that can affect patients on a psychological level. Studies show that the stigma can actually affect a patient’s level of care and lead to worse health outcomes, according to Jennifer King, senior director of science and research for GO2 Foundation for Lung Cancer.

Patients with lung cancer who feel stigmatized, particularly if they have a history of smoking tobacco products, often hesitate to seek support and speak with loved ones about their disease, according to King. As a result of the stigma and perceived lack of sympathy or support, patients with lung cancer can be more prone to depression and other psychosocial issues.

“It can even impact their level of care,” said King. “Many patients report that they feel less sympathy, that they don’t feel that their level of care is as good because they are a (patient with lung cancer) versus a patient with a different type of cancer.”

At the 2019 American Society of Clinical Oncology Annual (ASCO) Meeting, King discussed this stigma and how it affects patients psychologically and physically. She also spoke about the disparities in care that patients with lung cancer often face when seeking treatment.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Minimally Invasive Surgery Transforms Lung Cancer Recovery
Image of man with text.
Six-time cancer survivor Staci Kirk urges patients to trust their bodies and speak up to ensure their needs are understood and addressed throughout cancer care.
Clinical trials should be designed to ease travel and financial burdens by using local care, telehealth and remote tools, Kimberly Demirhan explained.
Image of man with text.
Image of woman with text.
Image of woman, with text.
Enabling patients to generate CAR T-cells internally could cut kidney cancer therapy costs, explained Dr. Wayne Marasco of Dana-Farber Cancer Institute.
Woman with text.
Kidney Cancer Research Embraces Biology-Driven Precision Approach